PRPH - ProPhase Labs - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

PRPH is currently covered by 1 analysts with an average price target of $12.31. This is a potential upside of $6.05 (96.65%) from yesterday's end of day stock price of $6.26.

ProPhase Labs's activity chart (see below) currently has 3 price targets and 15 ratings on display. The stock rating distribution of PRPH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 14.29% with an average time for these price targets to be met of 121 days.

Highest price target for PRPH is $11, Lowest price target is $11, average price target is $12.31.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 21-Feb-2024. First documented stock forecast 20-Dec-2021.

Best performing analysts who are covering PRPH - ProPhase Labs:

Yi Chen

Currently out of the existing stock ratings of PRPH, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

11

$4.74 (75.72%)

11

1 months 7 days ago

2/14 (14.29%)

$6.05 (122.22%)

121

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRPH (ProPhase Labs) average time for price targets to be met?

On average it took 121 days on average for the stock forecasts to be realized with a an average price target met ratio 14.29

Which analyst has the current highest performing score on PRPH (ProPhase Labs) with a proven track record?

YI CHEN

Which analyst has the most public recommendations on PRPH (ProPhase Labs)?

Yi Chen has 24 price targets and 15 ratings on PRPH

Which analyst is the currently most bullish on PRPH (ProPhase Labs)?

Yi Chen with highest potential upside - $4.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?